PRISMAP Survey

We welcome you to participate in our effort in creating the first European medical radionuclide infrastructure map with well-established distribution routes, expertise, harmonized legislation and research opportunities by filling this survey prepared by the PRISMAP Industrial collaboration team.

Take this opportunity to gain new research and international collaboration partners, benefit from harmonized supply and legislation procedures, expand Your network and distribution routes, and gain visibility within the PRISMAP User Forum map. Active respondents of the survey will be offered to participate in the preparation of the pooled results publication.

The survey consists of 3 branches and the subsequent questions are answer dependent:

  1. Radionuclide/ Radiopharmaceutical manufacturers and distributors;
  2. Research (including semi-academia) and education;
  3. Clinical user (hospitals, clinics, and professional organizations).

This survey is conducted to reach the following aims:

  • Identify key players in the industrial, research and clinical communities in the context of PRISMAP and investigate the needs of industrial, scientific and clinical end-users in nuclear medicine
  • Analyse the current facility profiles, geographic location, capabilities, licensing, logistics, future research and development perspectives, challenges, and needs for collaboration and improvement

PRISMAP newsletter features

The editorial content of our newsletter is available on this page.